Evidence map›Paper›PMID 20805509›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage.

Jun Wang, Tapasree Roy Sarkar, Ming Zhou, Shikha Sharan, Daniel A Ritt, Timothy D Veenstra, Deborah K Morrison, A-Mei Huang, Esta Sterneck

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The many faces of C/EBPδ and their relevance for inflammation and cancer.International journal of biological sciences · 2013
    Review
  19. ARL13B, PDE6D, and CEP164 form a functional network for INPP5E ciliary targeting.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Jun WangLaboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Tapasree Roy Sarkar
Ming Zhou
Shikha Sharan
Daniel A Ritt
Timothy D Veenstra
Deborah K Morrison
A-Mei Huang
Esta Sterneck
Center for Cancer Research · USFrederick National Laboratory for Cancer Research · USNational Cancer Institute · USScience Applications International Corporation (United States) · US

Funding

Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor CellsZIABC010307 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI STERNECK, GISELA · 2009 to 2025
$22.1M
Protein Chemistry CoreZICBC011083 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MORRISON, DEBORAH · 2009 to 2012
$757k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIC BC011083NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Maintenance of genomic integrity is an essential cellular function. We previously reported that the transcription factor and tumor suppressor CCAAT/enhancer binding protein δ (C/EBPδ, CEBPD; also known as "NFIL-6β") promotes genomic stability. However, the molecular mechanism was not known. Here, we show that C/EBPδ is a DNA damage-induced gene, which supports survival of mouse bone marrow cells, mouse embryo fibroblasts (MEF), human fibroblasts, and breast tumor cells in response to the DNA cross-linking agent mitomycin C (MMC). Using gene knockout, protein depletion, and overexpression studies, we found that C/EBPδ promotes monoubiquitination of the Fanconi anemia complementation group D2 protein (FANCD2), which is necessary for its function in replication-associated DNA repair. C/EBPδ interacts with FANCD2 and importin 4 (IPO4, also known as "Imp4" and "RanBP4") via separate domains, mediating FANCD2-IPO4 association and augmenting nuclear import of FANCD2, a prerequisite for its monoubiquitination. This study identifies a transcription-independent activity of C/EBPδ in the DNA damage response that may in part underlie its tumor suppressor function. Furthermore, we report a function of IPO4 and nuclear import in the Fanconi anemia pathway of DNA repair.

Indexed as

DNA DamageActive Transport, Cell NucleusAnimalsCCAAT-Enhancer-Binding Protein-deltaCell LineCell SurvivalFanconi Anemia Complementation Group D2 ProteinHumansKaryopherinsMembrane Transport ProteinsMiceMice, KnockoutProtein BindingUbiquitinationCCAAT-Enhancer-Binding Protein-deltaCEBPD protein, humanCebpd protein, mouseFANCD2 protein, humanFancd2 protein, mouseFanconi Anemia Complementation Group D2 Proteinimportin 4, mouseIPO4 protein, humanKaryopherinsMembrane Transport Proteins

Identifiers

PMID20805509
PMCPMC2941265
OpenAlexW1994871934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.